Cash flows across global energy and defense sectors swelled in the second quarter of 2026, according to recent corporate filings, contrasting sharply with a wave of desperate capital raises and asset fire sales by smaller health and tech firms. The disparity highlights a bifurcated market where large-cap incumbents are generating outsized profits while micro-caps restructure heavily to maintain liquidity.

TotalEnergies SE (TTE.US)

The French energy major reported second-quarter 2026 adjusted net income of USD 6B and cash flow of USD 9.8B, benefiting significantly from elevated Brent oil prices. Upstream production grew over 4% year-on-year, outperforming estimates, according to the company. The stock has rallied recently on the back of strong refining margins, with executives noting that the integrated power segment's cash flow jumped 25% sequentially.

Mosaic Co (MOS.US)

The fertilizer producer reported a second-quarter 2026 net loss of USD 273M on net sales of USD 2.8B, driven by unsustainably high sulfur prices and elevated idle costs. In response, the company is aggressively managing its balance sheet, cutting 2026 capital expenditures to USD 1.2B. The company expects third-quarter phosphate earnings to face continued pressure from high raw material costs, according to management commentary.

AEVEX Corporation (AVEX.US)

The U.S. defense technology firm is targeting robust growth, posting first-quarter 2026 revenue of USD 216.7M and net income of USD 21.0M. The drone player's stock recently surged over 40% in a week following government funding announcements for autonomous unmanned systems. The company projected full-year revenue of up to USD 620M and Adjusted EBITDA nearing USD 94.5M.

Bruker Corporation (BRKR.US)

The scientific instruments maker recorded Q2 2026 revenue of USD 838.5M, up 5.2% year-on-year. However, an unexpected USD 134.9M goodwill impairment pushed the company into a net loss of USD 62.9M. "We are committed to advancing our technological edge," the company stated in August, launching next-generation detectors for nanoscale characterization designed for semiconductor and energy materials applications.

VSee Health Inc (VSEE.US)

The telehealth firm is nearing a deal to invest USD 42M to acquire a vertically integrated healthcare commerce platform, a move expected to add over USD 35M in annualized revenue. The company's hospital network expanded 20-fold to 58 locations in mid-2026. Management reiterated a focus on minimizing shareholder dilution during this aggressive expansion phase.

Propanc Biopharma Inc (PPCB.US)

The development-stage healthcare company published positive preclinical data in August 2026 showing its PRP compound inhibited pancreatic tumor growth by over 90%. In a bid to boost its market valuation, the company recently completed the first USD 500,000 tranche of a planned USD 5M share buyback program, signaling management's confidence ahead of upcoming Phase 1b human trials.

Ohmyhome Limited (OMH.US)

The real estate platform sold off its core brokerage business for a nominal USD 1 in June 2026, pivoting to focus purely on digital marketing after waiving USD 14.7M in subsidiary debt. To secure liquidity, the company announced a USD 4M registered direct offering in late July, issuing shares to institutional investors, according to people familiar with the matter.

Haoxi Health Technology Ltd (HAO.US)

The Beijing-based online marketing provider followed a similar capital-raising path, announcing a USD 4M registered direct offering in July 2026. The firm issued 10 million Class A ordinary shares alongside pre-funded warrants. This move follows a massive 1-for-128 reverse stock split executed earlier in the year to regain compliance with listing requirements.

Meiwu Technology Company Limited (WNW.US)

The functional skincare company sold its dormant SMS service subsidiary and Mahao BVI unit for USD 100 each in July 2026, according to regulatory filings. The disposals are part of a broader effort to streamline operations following a 1-for-100 reverse stock split. The company is actively pursuing new AI-driven product strategies to stabilize revenue.

SMJ Intl Hldgs Inc (SMJF.US)

The Singapore-based premium flooring specialist filed its fiscal 2026 annual report in late July, confirming its sustained focus on Asian commercial and institutional sectors. Shares have edged higher recently, approaching key technical resistance levels amid slight upticks in institutional trading volume.

This article does not constitute investment advice.